Conditions: Healthy
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 18
Healthy volunteers: yes

Brief summary:
This study is being conducted to investigate the rate and extent of naproxen absorption from the Test naproxen sodium formulation is bioequivalent to Aleve® naproxen sodium, a Reference product currently marketed in The Netherlands in order to support the registration of the Reckitt Benckiser (RB) naproxen sodium (220 mg tablets).

Detailed description:

Arms:
arm 1: Treatment Order: Test, Reference arm 2: Treatment Order: Reference, Test

Interventions: intervention 1: Test intervention 2: Reference
Intervention descriptions: intervention 1: RB naproxen sodium tablets (2x220mg) intervention 2: Aleve naproxen sodium tablets (2x220mg)

Protocol document: